Biopharmaceuticals
Oncology
News Release - October 6, 2016
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
Source: Teva Pharmaceutical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.